Our world class Daisy Research facility focuses on cancer scanning and is evolving to provide equivalent services for heart diseases and specific neurological diseases, including dementia.
We are aiming to build a £6.4m radiochemistry and cyclotron unit so we can produce our own radioactive tracers. This will allow us to scan patients with certain heart and neurological conditions, including Alzheimer’s, as well as those with cancer.
Our trust has grown quite a reputation for its contribution to research, a greater understanding of disease, and the development of new treatments for the benefit of patients, relatives, carers, staff and the wider NHS.
Here are a few examples:
- Exemplary research and development into the causes of heart disease and cancer.
- One of the most advanced and best equipped Emergency Departments in the UK.
- Groundbreaking robotic-assisted surgery.
- Recognised as a major trauma centre.
- The first UK trust to perform mitral valve surgery.
- World class cancer facilities at the Queen's Centre.
- Over 450 research studies at any single time.
- Brand new, purpose-built Diabetes Research Centre.
- 22 national clinical audits reviewed by HUTH NHS Trust in 2020/21.
- 27 Covid-19 studies involving 2,500 participants.
- 1 in every 45 participants in global trial of Oxford/Astra Zeneca vaccine recruited by HUTH team.
- Exemplary research and development into the causes of heart disease and cancer.
- Research and Development income £6,100,000.